TY  - GEN
AU  - Resende,C B
AU  - Rezende,B M
AU  - Bernardes,P T T
AU  - Teixeira,G M
AU  - Teixeira,M M
AU  - Pinho,V
AU  - Bittencourt,H
TI  - Alemtuzumab as graft-versus-host disease (GVHD) prophylaxis strategy in a developing country: lower rate of acute GVHD, increased risk of cytomegalovirus reactivation
SN  - 1414-431X
PY  - 2017///1113
KW  - Adolescent
KW  - Adult
KW  - Alemtuzumab
KW  - Antibodies, Monoclonal, Humanized
KW  - therapeutic use
KW  - Child
KW  - Child, Preschool
KW  - Cytomegalovirus
KW  - physiology
KW  - Cytomegalovirus Infections
KW  - prevention & control
KW  - Disease-Free Survival
KW  - Female
KW  - Graft vs Host Disease
KW  - Hematopoietic Stem Cell Transplantation
KW  - adverse effects
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Prospective Studies
KW  - Risk Factors
KW  - Transplantation, Homologous
KW  - Virus Activation
KW  - drug effects
KW  - Young Adult
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1590/1414-431X20165566
ER  -